Measurement of outcomes and other variables of interest
bleeding, headaches, irregular vaginal bleeding, breast pain, Weight gain
BLEEDING
Socio-demographic characteristics were collected. Data collectors recorded the date of implant insertion or the date of DSG initiation. The main outcome variable for this study was method discontinuation. Secondary outcomes were the side effects, tolerance and satisfaction 3 months after inclusion and 12 months after ENG-IMPLANT insertion.A satisfaction questionnaire and a bleeding calendar was used to assess bleeding patterns throughout the first 3 months of use in both groups. Overall, irregular vaginal bleeding was defined as any deviation from their habitual menstrual patterns of bleeding.The satisfaction questionnaire evaluated side effects on skin, mood, sex-drive, abdomino-pelvic or breast pain, headaches, changes to vaginal discharge, and irregular vaginal bleeding according to a graded 5 points Likert score, from never experiencing (1 point) to all the time experiencing (5 points). Two separate questions evaluated tolerance and satisfaction and were graded on a scale from 0 to 10 (0 not tolerating or unsatisfied with the method and 10 being totally satisfied and perfectly tolerating). Weight gain as cause for removal was noted when relevant.